This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Dr. Lei Guo, Ph.D.
Senior Director, CRO Services at Wuxi Biologics, China
Speaker

Profile

Dr. Lei Guo leads the Protein Analytical Chemistry group in the CRO Services Department at WuXi Biologics. Her team specializes in comprehensive analytical testing of monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and fusion proteins during drug discovery and optimization stages, employing Mass Spectrometry and physicochemical & biophysical analyses. With over 16 years of experience in bioanalysis, Dr. Guo has held diverse roles at Pfizer, Sanofi, and MSD, contributing to target identification, lead optimization, drug development, and CMC-stage analytical support.

Agenda Sessions

  • Early-Stage Developability Assessment for Bispecific Antibody Lead Optimization and Selection

    11:00